Key Financial Data Of Reporting Company

COSMOS Pharmaceutical Corporation - Filing #7720512

Concept 2017-06-01 to
2018-05-31
2017-06-01 to
2018-05-31
As at
2018-05-31
As at
2018-05-31
2016-06-01 to
2017-05-31
As at
2017-05-31
As at
2017-05-31
2016-06-01 to
2017-05-31
2015-06-01 to
2016-05-31
As at
2016-05-31
As at
2016-05-31
2015-06-01 to
2016-05-31
2014-06-01 to
2015-05-31
2014-06-01 to
2015-05-31
As at
2015-05-31
As at
2015-05-31
2013-06-01 to
2014-05-31
2013-06-01 to
2014-05-31
As at
2014-05-31
As at
2014-05-31
Key financial data of reporting company
Business results of reporting company
Net sales
557,999,000,000 JPY
557,997,000,000 JPY
502,732,000,000 JPY
502,730,000,000 JPY
447,273,000,000 JPY
447,271,000,000 JPY
408,462,000,000 JPY
408,466,000,000 JPY
371,801,000,000 JPY
371,825,000,000 JPY
Ordinary profit (loss)
25,255,000,000 JPY
25,237,000,000 JPY
24,591,000,000 JPY
24,559,000,000 JPY
20,691,000,000 JPY
20,666,000,000 JPY
19,388,000,000 JPY
19,028,000,000 JPY
18,074,000,000 JPY
18,193,000,000 JPY
Profit (loss)
17,622,000,000 JPY
18,194,000,000 JPY
12,419,000,000 JPY
12,069,000,000 JPY
10,531,000,000 JPY
Share capital
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
Total number of issued shares
20,000,400 xbrli:shares
20,000,400 xbrli:shares
20,000,400 xbrli:shares
20,000,400 xbrli:shares
20,000,400 xbrli:shares
Net assets
108,638,000,000 JPY
108,888,000,000 JPY
92,797,000,000 JPY
93,053,000,000 JPY
75,990,000,000 JPY
76,179,000,000 JPY
64,821,000,000 JPY
65,055,000,000 JPY
53,791,000,000 JPY
54,399,000,000 JPY
Total assets
250,213,000,000 JPY
250,609,000,000 JPY
225,306,000,000 JPY
225,691,000,000 JPY
202,218,000,000 JPY
202,595,000,000 JPY
168,576,000,000 JPY
168,918,000,000 JPY
141,959,000,000 JPY
142,700,000,000 JPY
Net assets per share
5,486.90
5,499.55
4,686.83
4,699.76
3,837.97
3,847.52
3,273.87
3,285.70
2,716.78
2,747.50
Dividend paid per share
90.00
80.00
65.00
60.00
55.00
Interim dividend paid per share
45.00
35.00
30.00
27.50
25.00
Basic earnings (loss) per share
890.59
890.05
919.99
918.95
628.05
627.27
609.59
590.63
531.89
535.41
Diluted earnings per share
Equity-to-asset ratio
0.434 xbrli:pure
0.434 xbrli:pure
0.412 xbrli:pure
0.412 xbrli:pure
0.376 xbrli:pure
0.376 xbrli:pure
0.385 xbrli:pure
0.385 xbrli:pure
0.379 xbrli:pure
0.381 xbrli:pure
Rate of return on equity
0.175 xbrli:pure
0.175 xbrli:pure
0.215 xbrli:pure
0.216 xbrli:pure
0.176 xbrli:pure
0.176 xbrli:pure
0.204 xbrli:pure
0.196 xbrli:pure
0.215 xbrli:pure
0.213 xbrli:pure
Price-earnings ratio
26.3 xbrli:pure
26.4 xbrli:pure
25.4 xbrli:pure
25.4 xbrli:pure
31.7 xbrli:pure
31.7 xbrli:pure
27.7 xbrli:pure
28.6 xbrli:pure
19.7 xbrli:pure
19.6 xbrli:pure
Payout ratio
0.101 xbrli:pure
0.087 xbrli:pure
0.104 xbrli:pure
0.098 xbrli:pure
0.103 xbrli:pure
Net cash provided by (used in) operating activities
32,586,000,000 JPY
36,938,000,000 JPY
30,986,000,000 JPY
19,454,000,000 JPY
25,962,000,000 JPY
Net cash provided by (used in) investing activities
-30,458,000,000 JPY
-28,404,000,000 JPY
-28,550,000,000 JPY
-29,272,000,000 JPY
-20,118,000,000 JPY
Net cash provided by (used in) financing activities
-8,188,000,000 JPY
-8,088,000,000 JPY
6,211,000,000 JPY
7,151,000,000 JPY
-452,000,000 JPY
Cash and cash equivalents
21,668,000,000 JPY
27,728,000,000 JPY
27,282,000,000 JPY
18,635,000,000 JPY
21,302,000,000 JPY
Number of employees
3,841 xbrli:pure
3,849 xbrli:pure
3,526 xbrli:pure
3,533 xbrli:pure
3,009 xbrli:pure
3,016 xbrli:pure
2,700 xbrli:pure
2,706 xbrli:pure
2,318 xbrli:pure
2,323 xbrli:pure
Average number of temporary employees
12,142 xbrli:pure
12,199 xbrli:pure
10,850 xbrli:pure
10,910 xbrli:pure
9,526 xbrli:pure
9,586 xbrli:pure
8,769 xbrli:pure
8,820 xbrli:pure
7,712 xbrli:pure
7,762 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.